BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20888802)

  • 1. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.
    Han L; Yang Y; Yue X; Huang K; Liu X; Pu P; Jiang H; Yan W; Jiang T; Kang C
    Brain Res; 2010 Dec; 1366():9-17. PubMed ID: 20888802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
    Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells.
    Yue X; Lan F; Yang W; Yang Y; Han L; Zhang A; Liu J; Zeng H; Jiang T; Pu P; Kang C
    Brain Res; 2010 Dec; 1366():27-37. PubMed ID: 20969832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway.
    Ren Y; Zhou X; Qi Y; Li G; Mei M; Yao Z
    Oncol Rep; 2012 Sep; 28(3):943-8. PubMed ID: 22710837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-Kinase Mediates β-Catenin Dysfunction of Airway Epithelium in a Toluene Diisocyanate-Induced Murine Asthma Model.
    Yao L; Zhao H; Tang H; Song J; Dong H; Zou F; Cai S
    Toxicol Sci; 2015 Sep; 147(1):168-77. PubMed ID: 26089345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 7. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
    Lau MT; Klausen C; Leung PC
    Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
    Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
    PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
    Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
    Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
    Pu P; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H
    Cancer Gene Ther; 2009 Apr; 16(4):351-61. PubMed ID: 18949017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma.
    Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B
    Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
    Liu S; Vinall RL; Tepper C; Shi XB; Xue LR; Ma AH; Wang LY; Fitzgerald LD; Wu Z; Gandour-Edwards R; deVere White RW; Kung HJ
    Oncogene; 2008 Jan; 27(4):499-505. PubMed ID: 17653089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
    Wang L; Shao YY; Ballock RT
    J Bone Miner Res; 2010 May; 25(5):1138-46. PubMed ID: 20200966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy.
    Sourbier C; Lindner V; Lang H; Agouni A; Schordan E; Danilin S; Rothhut S; Jacqmin D; Helwig JJ; Massfelder T
    Cancer Res; 2006 May; 66(10):5130-42. PubMed ID: 16707436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
    Mikami I; Zhang F; Hirata T; Okamoto J; Koizumi K; Shimizu K; Jablons D; He B
    Oncol Rep; 2010 Dec; 24(6):1677-81. PubMed ID: 21042767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
    Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
    Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.